ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $5,543,000 | +3.4% | 142,740 | -8.3% | 0.15% | +8.1% |
| Q2 2014 | $5,362,000 | -34.0% | 155,620 | -17.2% | 0.14% | -18.6% |
| Q1 2014 | $8,119,000 | +6.7% | 187,880 | -1.6% | 0.17% | +3.7% |
| Q4 2013 | $7,607,000 | +2.4% | 190,930 | -3.5% | 0.16% | 0.0% |
| Q3 2013 | $7,426,000 | +39.7% | 197,800 | 0.0% | 0.16% | +57.8% |
| Q2 2013 | $5,315,000 | – | 197,800 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |